Anisimova confronts online weight-loss drug rumors
American tennis player Amanda Anisimova denied using the weight-loss drug Ozempic after online commentators targeted her recent physical changes on social media, mt.co.kr reported. The 25-year-old athlete, who holds a social media following of more than 520,000, addressed the speculation directly on her Instagram story before deleting the post.
Direct pushback on Instagram
Anisimova posted photographs displaying her current physique, which prompted certain social media users to claim she had used dietary injections.
In response, Anisimova wrote on her Instagram account: “To all the health experts and body critics living in the comment section, I am not on Ozempic. Please leave me alone and keep me out of your weird posts.” The post was subsequently removed, mt.co.kr reported.
A history of public commentary
The recent scrutiny follows previous public commentary regarding Anisimova’s appearance.
The player previously stepped away from the tennis tour after receiving online criticism that targeted her shoulders and chest. Following the Madrid Open in 2023, she stated that she could not understand individuals who evaluated her body daily and questioned the public fixation on athletes’ physical forms, leading to her temporary hiatus from competition.
Anisimova reaches career-high ranking after winning titles
After spending time away from the sport with family and friends at home, Anisimova returned to the WTA tour and experienced a resurgence in her career.
She captured titles at the WTA 1000 events in Doha and Beijing in 2025, reached the finals at Wimbledon and the US Open, and achieved a career-high singles ranking of world No. 3 in January. She currently holds the No. 11 spot in the WTA rankings.
Worth a look
